相关实验视频

Updated: Apr 23, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

达丁治疗拯救了FGFR3骨发育不良现象的类型

Akihiro Yamashita¹, Miho Morioka¹, Hiromi Kishi¹

¹Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.

|September 19, 2014

概括

类药物可以通过改善患者干细胞的软骨和小鼠的骨生长来治疗骨功能障碍,如骨质疏松症. 这为治疗这些罕见的遗传疾病提供了希望.

科学领域:

遗传学和发育生物学
干细胞研究干细胞研究
药理学药理学是指药理学的学科.

背景情况:

纤维细胞生长因子受体3 (FGFR3) 的功能获取突变会导致骨性形,包括多形形 (TD1) 和无形形 (ACH).
缺乏基于人类细胞的疾病模型,阻碍了对这些疾病的有效治疗方法的开发.

研究的目的:

在患者特异性诱导多能干细胞 (iPSC) 模型和FGFR3骨发育不良的小鼠模型中研究他类药物的治疗潜力.
确定他类药物治疗是否可以拯救与TD1和ACH相关的细胞和体内表型.

主要方法:

来自TD1和ACH患者的纤维细胞被转化为iPSC.
iPSCs经历了冠状体差异化以模拟软骨发育.
患者衍生的iPSC衍生的软骨和ACH小鼠模型被治疗了他类药物.
在小鼠模型中评估了骨生长恢复.

主要成果:

对TD1和ACH iPSCs的同基分化导致了软骨的退化.
在TD1和ACH iPSC模型中,他治疗纠正了软骨退化.
在ACH小鼠模型中,静止剂的使用显著改善了骨生长.

结论:

类药物对与FGFR3相关的骨功能障碍有治疗潜力.
在TD1和ACH模型中,他类药物治疗可以挽救细胞缺陷并促进骨生长.
类药物可能为被诊断为TD1和ACH的婴儿和儿童提供可行的医疗治疗.

更多相关视频

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...